JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells.
about
"You Shall Not Pass"-tight junctions of the blood brain barrierCellular localization of nectin-1 and glycoprotein D during herpes simplex virus infectionJunctional adhesion molecule-C is a soluble mediator of angiogenesisThe cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM)Lymphatic endothelium: morphological, molecular and functional propertiesParadigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesisTension on JAM-A activates RhoA via GEF-H1 and p115 RhoGEF.Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic PlaquesX-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motifCrystal structure of human junctional adhesion molecule 1: Implications for reovirus bindingBrain barriers: Crosstalk between complex tight junctions and adherens junctionsA transmembrane tight junction protein selectively expressed on endothelial cells and plateletsJAM2 interacts with alpha4beta1. Facilitation by JAM3The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactionsReactive oxygen species in inflammation and tissue injuryGenetic deletion of JAM-C reveals a role in myeloid progenitor generationPulmonary dysfunction and impaired granulocyte homeostasis result in poor survival of Jam-C-deficient miceJAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1Novel distribution of junctional adhesion molecule-C in the neural retina and retinal pigment epitheliumThe spatiotemporal localization of JAM-C following sciatic nerve crush in adult ratsDual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesionLoss of partitioning-defective-3/isotype-specific interacting protein (par-3/ASIP) in the elongating spermatid of RA175 (IGSF4A/SynCAM)-deficient miceJAM-C regulates tight junctions and integrin-mediated cell adhesion and migrationExpression and function of junctional adhesion molecule-C in myelinated peripheral nervesTargeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARĪ± mediated mechanismJunctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury.Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.Evidence for cross-reactivity of JAM-C antibodies: implications for cellular localization studies.CAR modulates E-cadherin dynamics in the presence of adenovirus type 5.Jamb and jamc are essential for vertebrate myocyte fusionAndrogens regulate the permeability of the blood-testis barrier.A homozygous mutation in the tight-junction protein JAM3 causes hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts.Oligo-astheno-teratozoospermia in mice lacking RA175/TSLC1/SynCAM/IGSF4A, a cell adhesion molecule in the immunoglobulin superfamilyJunctional adhesion molecule (JAM)-C deficient C57BL/6 mice develop a severe hydrocephalus.The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.Blockade but not overexpression of the junctional adhesion molecule C influences virus-induced type 1 diabetes in mice.Blocking junctional adhesion molecule C enhances dendritic cell migration and boosts the immune responses against Leishmania major.Junctional Adhesion Molecules (JAMs) are differentially expressed in fibroblasts and co-localize with ZO-1 to adherens-like junctions.Sertoli cell tight junction dynamics: their regulation during spermatogenesis.A CTX family cell adhesion molecule, JAM4, is expressed in stem cell and progenitor cell populations of both male germ cell and hematopoietic cell lineages
P2860
Q21129349-D4843167-13BA-42EC-A99A-D71F33CD1ECAQ24311876-7F7641A5-B499-44E2-BF77-9055FEF2424CQ24337026-18E00F3F-BAA3-4243-8468-91B934F152FFQ24534460-4EDD4686-2B04-4094-90AE-E989D530BA1DQ24672687-862D37D8-7A36-45EE-A7BD-B9F398DD8D91Q26787279-54F27CE5-6153-45D9-B7C4-0B449EDD53EEQ27304828-1BA275C1-F492-4BD2-9A7F-B6848A950737Q27333694-F0F7EF70-CE9E-45E0-9A65-1FC56EAF533DQ27634027-2BA2A610-15FA-4E16-B35B-60CFF511C3E3Q27640992-E62EAF4E-F243-45F6-A7BB-E69AFFDAE760Q28083498-F484AEF6-6DC9-4A08-91F4-E2EF83A03E16Q28201696-27C1EAFC-306D-4415-BFA6-4963A861CE51Q28205206-F3EA47A7-03FF-4AF9-B8CF-71B242CB7C55Q28268648-CEB426AE-B853-48C2-BBBA-101A2B90D03EQ28396273-352E3A45-FD12-499C-8531-02F21681CB02Q28504832-C4C58B85-1E3E-4AE1-B9B2-6A3D9BA7B485Q28506472-210FC438-7B26-45D4-86A9-5937E5CCCA15Q28506613-69AE2402-C249-4600-8F24-44DF2EE5A150Q28509369-0BB0BB16-8BAB-42C1-A9E6-4DC42BE795EDQ28580121-1A5AC86C-3838-4ABB-9502-77FDB003992CQ28587829-28FC5D2C-0732-4D91-B0A7-23E3F181176EQ28588532-CBF0A80D-7070-4BC6-A2A1-A53DFA339625Q28588755-EDE6F3E5-CD89-4C2F-B87D-C2C3BE5955ECQ28594443-2754C9E2-EAB0-432F-B1A1-7EA26AB9ABE1Q28743072-8F462295-40C9-4C00-937D-9E3A5D0BDCB5Q30476048-F1EABA5A-7EFB-4370-94BD-E2083586606AQ33676881-4F3A749A-A79D-4436-AB2B-E0AFD9BCFCD7Q33879914-14E43D76-FA2D-4CA8-A907-CAC9B7477DCEQ33995638-9B1F9117-BB70-459F-A094-17F5FB474D30Q34105131-D4A5B962-8BC5-4DA8-B258-54E6207C6769Q34133262-03E1B463-C415-4C61-AF08-1BED24C5A5CDQ34151916-664F1C58-43B0-4BED-AFD5-A79D53691519Q34301973-B798B1FC-BCC8-4BD2-8276-7D8B41EF4183Q34429627-3C46FECC-339F-4A00-82B7-F4B9486FEA7FQ34568855-145F45B4-8185-4CED-97DC-BB7B71D96D95Q34571265-141DE3BE-091E-4D9A-8132-D81A97F8DE97Q34634796-049E5718-1783-429D-A77F-62171A2DEBDBQ34652725-739CBA62-A8B8-47CC-A76A-155F0F98846EQ35073616-3C9D686D-CCB6-4DC2-AEF7-760A66AEE4E5Q35131498-2C9FB042-0EBB-4F2D-90D3-5A9F555A686E
P2860
JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells.
description
2000 nĆ® lÅ«n-bĆ»n
@nan
2000 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕøÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2000 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ°ÕøÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2000幓ć®č«ę
@ja
2000幓å¦ęÆęē«
@wuu
2000幓å¦ęÆęē«
@zh-cn
2000幓å¦ęÆęē«
@zh-hans
2000幓å¦ęÆęē«
@zh-my
2000幓å¦ęÆęē«
@zh-sg
2000幓åøč”ęē«
@yue
name
JAM-2, a novel immunoglobulin ...... dothelial and lymphatic cells.
@ast
JAM-2, a novel immunoglobulin ...... dothelial and lymphatic cells.
@en
JAM-2, a novel immunoglobulin ...... dothelial and lymphatic cells.
@nl
type
label
JAM-2, a novel immunoglobulin ...... dothelial and lymphatic cells.
@ast
JAM-2, a novel immunoglobulin ...... dothelial and lymphatic cells.
@en
JAM-2, a novel immunoglobulin ...... dothelial and lymphatic cells.
@nl
prefLabel
JAM-2, a novel immunoglobulin ...... dothelial and lymphatic cells.
@ast
JAM-2, a novel immunoglobulin ...... dothelial and lymphatic cells.
@en
JAM-2, a novel immunoglobulin ...... dothelial and lymphatic cells.
@nl
P2093
P4510
P356
P1476
JAM-2, a novel immunoglobulin ...... dothelial and lymphatic cells.
@en
P2093
Aurrand-Lions M
Ballestrem C
P304
P356
10.1074/JBC.M005458200
P407
P577
2000-10-25T00:00:00Z